Search
Zoetis Inc
ZTSAdd to Watchlist
79.220USD
-2.890-3.52%
Market hours 11/06, 10:06（ET）
32.74BMarket Cap
13.11P/E TTM
Today
-3.52%
5 Days
+1.21%
1 Month
+11.69%
6 Months
-28.64%
Year to Date
-35.62%
1 Year
-32.77%
Key Figures
80.390Open
88.740High
761.99KVolume
13.11P/E TTM
12.33P/E Dynamic
2.060Dividend TTM
0.18%Turnover Ratio
82.110Prev. Close
78.870Low
60.90MTurnover
13.17P/E Static
10.40P/B
2.60%Div Yield TTM
18.07%ROA
130.12252wk High
1.27Volume Ratio
2.49BNet Profit
413.22MShares
6.0419EPS TTM
0.77Beta
67.01%ROE
68.30752wk Low
12.02%Amplitude
71.04%Gross Margin
32.74BMarket Cap
-1.95Reward/Risk
2.39%Risk Rate
Recent
Analysis
Earnings
Transcripts
Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know
• Novo Nordisk raised full-year sales and operating profit guidance amid strong metabolic drug demand. • Clinical data shows efficacy for cardiovascular and kidney diseases, expanding the potential patient base. • Current technical indicators show a neutral MACD signal and oversold Williams %R conditions.
TradingKeyThu, Aug 6
Insmed Inc Stock (INSM) Moved Up by 31.83% on Aug 6: Key Drivers Unveiled
• Insmed shares rose following positive clinical trial data and potential acquisition interest. • Analysts revised revenue models, setting an average price target of $196.74. • Technical indicators show a sell signal with the stock currently in oversold territory.
TradingKeyThu, Aug 6
Zoetis Inc's Score
-0.41vs previous score
Forecast6.67
Financial Health8.61
Technical4.30
Valuation Dimensions9.00
Institutional Confidence10.00
Risk Assessment6.61
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Zoetis Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Zoetis Inc Latest Earnings Call Transcripts
Zoetis (ZTS) Q3 2026 Earnings Call: Guidance Raised as Livestock Offsets Dermatology Pressure
Zoetis Q3 2026 revenue fell 1% to $2.4 billion as companion animal weakness offset livestock and diagnostics growth. FY2026 EPS guidance rose.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/1.51
Revenue / Forecast
--/2.30B
Zoetis Inc Profile
SectorPharmaceuticals
Ticker SymbolZTS
Number of employees13800
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.22% |
| Vanguard Portfolio Management, LLC | 5.72% |
| BlackRock Institutional Trust Company, N.A. | 5.67% |
| State Street Investment Management (US) | 4.72% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.29% |
| Investment Advisor/Hedge Fund | 33.37% |
| Research Firm | 4.25% |
| Insurance Company | 4.11% |
Related Instruments
+0.09%
-0.47%
-0.26%
-0.15%
-0.59%
-1.40%
-0.61%
-0.33%
-1.15%
-0.80%
-0.97%
-1.20%
-1.60%
-1.39%
+7.37%
-1.32%
-0.59%
-1.27%
-1.18%
+0.00%Popular Instruments
51332.200
-166.900 (-0.32%)
27141.400
+506.200 (+1.90%)
7410.400
+53.500 (+0.73%)
12797.000
-1.000 (-0.01%)
58391.000
+1125.000 (+1.97%)
6147.100
-30.700 (-0.50%)
89.977
-0.056 (-0.06%)
340.540
-3.630 (-1.05%)
192.700
+11.100 (+6.11%)
4044.350
-54.340 (-1.33%)
FAQs
What is the current price of Zoetis Inc (ZTS)?
The current price of Zoetis Inc (ZTS) is 82.11.
What is the symbol of Zoetis Inc?
The ticker symbol of Zoetis Inc is ZTS.
What is the 52-week high of Zoetis Inc?
The 52-week high of Zoetis Inc is 130.12.
What is the 52-week low of Zoetis Inc?
The 52-week low of Zoetis Inc is 68.31.
What is the market capitalization of Zoetis Inc?
The market capitalization of Zoetis Inc is 33.93B.
Is Zoetis Inc (ZTS) currently rated as Buy, Hold, or Sell?
According to analysts, Zoetis Inc (ZTS) has an overall rating of signal_hold, with a price target of 92.78.
What is the Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS)?
The Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS) is 6.04.